{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T08:31:13Z","timestamp":1793694673560,"version":"4.5.1"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,12,15]],"date-time":"2021-12-15T00:00:00Z","timestamp":1639526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,12,15]],"date-time":"2021-12-15T00:00:00Z","timestamp":1639526400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"published-print":{"date-parts":[[2022,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Hypersensitivity reactions including IgE-mediated and delayed cell-mediated reactions to aminoglycosides, clindamycin, linezolid, and metronidazole are rare. For aminoglycosides, allergic contact dermatitis is the most frequent reaction for which patch testing can be a useful step in evaluation. For clindamycin, delayed maculopapular exanthems are the most common reactions. There are case reports of clindamycin associated with drug rash with eosinophilia and systemic symptoms (DRESS), acute generalized exanthematous pustulosis (AGEP), acute febrile neutrophilic dermatosis, and symmetrical drug-related intertriginous and flexural exanthema (SDRIFE). For linezolid, cases of hypersensitivity were exceedingly rare and included urticaria, angioedema, anaphylaxis, delayed rashes, and DRESS. For metronidazole, only rare cases were found across a broad spectrum of reactions including allergic contact dermatitis, fixed drug eruption, angioedema, anaphylaxis, serum sickness-like reaction, SJS\/TEN, AGEP, SDRIFE, and a possible case of DRESS. IgE-mediated reactions and anaphylaxis to these types of antibiotics are uncommon, and reports of skin testing concentrations and desensitization protocols are largely limited to case reports and series. Non-irritating skin testing concentrations have been reported for gentamycin, tobramycin, and clindamycin. Published desensitization protocols for intravenous and inhaled tobramycin, oral clindamycin, intravenous linezolid, and oral and intravenous metronidazole have also been reported and are reviewed.<\/jats:p>","DOI":"10.1007\/s12016-021-08878-x","type":"journal-article","created":{"date-parts":[[2021,12,15]],"date-time":"2021-12-15T01:02:56Z","timestamp":1639530176000},"page":"463-475","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Immediate and Delayed Hypersensitivity Reactions to Antibiotics: Aminoglycosides, Clindamycin, Linezolid, and Metronidazole"],"prefix":"10.1007","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3175-3470","authenticated-orcid":false,"given":"Michelle","family":"Dilley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bob","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,12,15]]},"reference":[{"key":"8878_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/1939-4551-6-18","author":"M S\u00e1nchez-Borges","year":"2013","unstructured":"S\u00e1nchez-Borges M, Thong B, Blanca M et al (2013) Hypersensitivity reactions to non beta-lactam antimicrobial agents, a statement of the WAO special committee on drug allergy. World Allergy Organ J. https:\/\/doi.org\/10.1186\/1939-4551-6-18","journal-title":"World Allergy Organ J"},{"key":"8878_CR2","doi-asserted-by":"publisher","unstructured":"Krause KM, Krause KM, Serio AW, Kane TR, Connolly LE (2016) Aminoglycosides: an overview.\u201d\u00a0Cold Spring Harb Perspect Med. https:\/\/doi.org\/10.1101\/cshperspect.a027029","DOI":"10.1101\/cshperspect.a027029"},{"key":"8878_CR3","unstructured":"National Center for Biotechnology Information (2020) PubChem Compound Summary for CID 19649, Streptomycin. Retrieved from https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Streptomycin"},{"key":"8878_CR4","unstructured":"National Center for Biotechnology Information (2020) PubChem Compound Summary for CID 3467, Gentamicin. Retrieved from https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Gentamicin"},{"key":"8878_CR5","unstructured":"National Center for Biotechnology Information (2020) PubChem Compound Summary for CID 36294, Tobramycin. Retrieved from https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Tobramycin"},{"key":"8878_CR6","unstructured":"National Center for Biotechnology Information (2020) PubChem Compound Summary for CID 8378, Neomycin. Retrieved from https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Neomycin"},{"key":"8878_CR7","doi-asserted-by":"publisher","unstructured":"Childs-Kean LM, Shaeer KM, Varghese Gupta S, Cho JC (2019) Aminoglycoside allergic reactions. Pharmacy (Basel, Switzerland).\u00a0https:\/\/doi.org\/10.3390\/pharmacy7030124","DOI":"10.3390\/pharmacy7030124"},{"key":"8878_CR8","doi-asserted-by":"publisher","unstructured":"Chastain DB, Hutzley VB, Parekh J, Alegro JV (2019) Antimicrobial desensitization: a review of published protocols. Pharm: J Pharm Educ Practice. https:\/\/doi.org\/10.3390\/pharmacy7030112","DOI":"10.3390\/pharmacy7030112"},{"key":"8878_CR9","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1268","author":"MCA De P\u00e1dua","year":"2007","unstructured":"De P\u00e1dua MCA, Uter W, Schnuch A (2007) Contact allergy to topical drugs: prevalence in a clinical setting and estimation of frequency at the population level. Pharmacoepidemiol Drug Saf. https:\/\/doi.org\/10.1002\/pds.1268","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"8878_CR10","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1117","author":"MCA De P\u00e1dua","year":"2005","unstructured":"De P\u00e1dua MCA, Schnuch A, Lessmann H, Geier J, Pfahlberg A, Uter W (2005) Contact allergy to neomycin sulfate: results of a multifactorial analysis. Pharmacoepidemiol Drug Saf. https:\/\/doi.org\/10.1002\/pds.1117","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"8878_CR11","doi-asserted-by":"publisher","DOI":"10.1111\/cod.13209","author":"L Gilissen","year":"2019","unstructured":"Gilissen L, De Decker L, Hulshagen T, Goossens A (2019) Allergic contact dermatitis caused by topical ophthalmic medications: keep an eye on it. Contact Derm. https:\/\/doi.org\/10.1111\/cod.13209","journal-title":"Contact Derm"},{"key":"8878_CR12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2005.00588.x","author":"MR Gonz\u00e1lez-Mendiola","year":"2005","unstructured":"Gonz\u00e1lez-Mendiola MR, Balda GA, Delgado CM, Monta\u00f1o PP, De Olano GD, S\u00e1nchez-Cano M (2005) Contact allergy from tobramycin eyedrops. Allergy. https:\/\/doi.org\/10.1111\/j.1398-9995.2005.00588.x","journal-title":"Allergy"},{"key":"8878_CR13","doi-asserted-by":"publisher","DOI":"10.1111\/cod.13352","author":"M Corazza","year":"2019","unstructured":"Corazza M, Forconi R, Toni G, Scuderi V, Mantovani L, Borghi A (2019) Systemic allergic dermatitis due to gentamicin. Contact Derm. https:\/\/doi.org\/10.1111\/cod.13352","journal-title":"Contact Derm"},{"key":"8878_CR14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.2009.01666.x","author":"AC De Groot","year":"2010","unstructured":"De Groot AC, Maibach HI (2010) Frequency of sensitization to common allergens: comparison between Europe and the USA. Contact Derm. https:\/\/doi.org\/10.1111\/j.1600-0536.2009.01666.x","journal-title":"Contact Derm"},{"key":"8878_CR15","doi-asserted-by":"publisher","DOI":"10.1177\/1203475415623512","author":"JF Elliott","year":"2016","unstructured":"Elliott JF, Abbas M, Hull P, De Gannes G, Toussi R, Milani A (2016) Decreasing rates of neomycin sensitization in western Canada. J Cutan Med Surg. https:\/\/doi.org\/10.1177\/1203475415623512","journal-title":"J Cutan Med Surg"},{"key":"8878_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(87)90365-4","author":"HS Earl","year":"1987","unstructured":"Earl HS, Sullivan TJ (1987) Acute desensitization of a patient with cystic fibrosis allergic to both beta-lactam and aminoglycoside antibiotics. J Allergy Clin Immunol. https:\/\/doi.org\/10.1016\/0091-6749(87)90365-4","journal-title":"J Allergy Clin Immunol"},{"key":"8878_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.10049","author":"MG Spigarelli","year":"2002","unstructured":"Spigarelli MG, Hurwitz ME, Nasr SZ (2002) Hypersensitivity to inhaled TOBI\u00ae following reaction to gentamicin. Pediatr Pulmonol. https:\/\/doi.org\/10.1002\/ppul.10049","journal-title":"Pediatr Pulmonol"},{"key":"8878_CR18","doi-asserted-by":"publisher","unstructured":"Santos RP, Awa E, Anbar RD (2007). Inhaled tobramycin solution-associated recurrent eosinophilia and severe persistent bronchospasm in a patient with cystic fibrosis: a case report. BMC Pediatr. https:\/\/doi.org\/10.1186\/1471-2431-7-11","DOI":"10.1186\/1471-2431-7-11"},{"key":"8878_CR19","doi-asserted-by":"publisher","DOI":"10.1007\/s11845-007-0077-z","author":"M Connolly","year":"2007","unstructured":"Connolly M, McAdoo J, Bourke JF (2007) Gentamicin-induced anaphylaxis. Ir J Med Sci. https:\/\/doi.org\/10.1007\/s11845-007-0077-z","journal-title":"Ir J Med Sci"},{"key":"8878_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2016.07.003","author":"IS Christiansen","year":"2016","unstructured":"Christiansen IS, Pedersen P, Kr\u00f8igaard M, Mosbech H, Garvey LH (2016) Anaphylaxis to intravenous gentamicin with suspected sensitization through gentamicin-loaded bone cement. J Allergy Clin Immunol Pract. https:\/\/doi.org\/10.1016\/j.jaip.2016.07.003","journal-title":"J Allergy Clin Immunol Pract"},{"key":"8878_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/1939-4551-8-S1-A269","author":"CMG Henao","year":"2015","unstructured":"Henao CMG, Morales CIH, Villa RC, Henao AMC (2015) Gentamicin induced anaphylaxis, a case report. World Allergy Organ J. https:\/\/doi.org\/10.1186\/1939-4551-8-S1-A269","journal-title":"World Allergy Organ J"},{"key":"8878_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2013.11.002","author":"D Jung","year":"2014","unstructured":"Jung D, Kim J, Choi NY et al (2014) Anaphylaxis associated with streptomycin skin testing. Ann Allergy Asthma Immunol. https:\/\/doi.org\/10.1016\/j.anai.2013.11.002","journal-title":"Ann Allergy Asthma Immunol"},{"key":"8878_CR23","unstructured":"A\u00f1\u00edbarro B, Seoane FJ (2009) Immediate allergic reaction due to neomycin. J Investig Allergol Clin Immunol. PMID: 19274933"},{"key":"8878_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2012.05.042","author":"B Bensaid","year":"2012","unstructured":"Bensaid B, Rozieres A, Nosbaum A, Nicolas J, Berard F (2012) Amikacin-induced drug reaction with eosinophilia and systemic symptoms syndrome: delayed skin test and ELISPOT assay results allow the identification of the culprit drug. J Allergy Clin Immunol. https:\/\/doi.org\/10.1016\/j.jaci.2012.05.042","journal-title":"J Allergy Clin Immunol"},{"key":"8878_CR25","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2004.027953","author":"JS Parmar","year":"2005","unstructured":"Parmar JS, Nasser S (2005) Antibiotic allergy in cystic fibrosis. Thorax. https:\/\/doi.org\/10.1136\/thx.2004.027953","journal-title":"Thorax"},{"key":"8878_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2010.08.002","author":"R Solensky","year":"2010","unstructured":"Solensky R, Khan DA (2010) Drug allergy: an updated practice parameter. Ann Allergy Asthma Immunol. https:\/\/doi.org\/10.1016\/j.anai.2010.08.002","journal-title":"Ann Allergy Asthma Immunol"},{"key":"8878_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/s0091-6749(03)01783-4","author":"R Empedrad","year":"2003","unstructured":"Empedrad R, Darter AL, Earl HS, Gruchalla RS (2003) Nonirritating intradermal skin test concentrations for commonly prescribed antibiotics. J Allergy Clin Immunol. https:\/\/doi.org\/10.1016\/s0091-6749(03)01783-4 (PMID: 13679828)","journal-title":"J Allergy Clin Immunol"},{"key":"8878_CR28","unstructured":"Solensky R (2020) Hypersensitivity reactions to macrolides, aminoglycosides, tetracyclines, clindamycin, and metronidazole. UpToDate. Accessed from https:\/\/www.uptodate.com\/contents\/hypersensitivity-reactions-to-macrolides-aminoglycosides-tetracyclines-clindamycin-and-metronidazole"},{"key":"8878_CR29","unstructured":"Yoo JY, Al Naami M, Markowitz O, Hadi SM (2010) Allergic contact dermatitis: patch testing results at Mount Sinai Medical Center. Skinmed. PMID: 21137633"},{"key":"8878_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2011.02.002","author":"P Whitaker","year":"2011","unstructured":"Whitaker P, Shaw N, Gooi J, Etherington C, Conway S, Peckham D (2011) Rapid desensitization for non-immediate reactions in patients with cystic fibrosis. J Cyst Fibros. https:\/\/doi.org\/10.1016\/j.jcf.2011.02.002","journal-title":"J Cyst Fibros"},{"key":"8878_CR31","unstructured":"National Center for Biotechnology Information (2020) PubChem Compound Summary for CID 446598, Clindamycin. Retrieved from https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Clindamycin"},{"key":"8878_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2018.08.006","author":"K Rutkowski","year":"2019","unstructured":"Rutkowski K, Wagner A, Mirakian R, Thomas I (2019) Immediate hypersensitivity to clindamycin: rare, but not impossible. J Allergy Clin Immunol Pract. https:\/\/doi.org\/10.1016\/j.jaip.2018.08.006","journal-title":"J Allergy Clin Immunol Pract"},{"key":"8878_CR33","doi-asserted-by":"publisher","DOI":"10.1177\/0009922818805204","author":"NR Washington","year":"2019","unstructured":"Washington NR, Petersen K, Petersen M (2019) The clindamycin catastrophe: a case of antibiotic-induced skin eruption. Clin Pediatr. https:\/\/doi.org\/10.1177\/0009922818805204","journal-title":"Clin Pediatr"},{"key":"8878_CR34","unstructured":"Monteagudo B, Cabanillas M, Iriarte P et al (2018) Clindamycin-induced maculopapular exanthema with preferential involvement of striae distensae: a koebner phenomenon? Acta Dermatovenerol Croat.\u00a0PMID: 29782303"},{"key":"8878_CR35","doi-asserted-by":"publisher","DOI":"10.1111\/cod.13133","author":"S Veraldi","year":"2019","unstructured":"Veraldi S, Guanziroli E, Ferrucci S, Nazzaro G (2019) Allergic contact dermatitis caused by clindamycin. Contact Derm. https:\/\/doi.org\/10.1111\/cod.13133","journal-title":"Contact Derm"},{"key":"8878_CR36","doi-asserted-by":"publisher","DOI":"10.1111\/cod.12784","author":"P Romita","year":"2017","unstructured":"Romita P, Ettorre G, Corazza M, Borghi A, Foti C (2017) Allergic contact dermatitis caused by clindamycin mimicking \u2018retinoid flare.\u2019 Contact Derm. https:\/\/doi.org\/10.1111\/cod.12784","journal-title":"Contact Derm"},{"key":"8878_CR37","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.5711.703","author":"AM Geddes","year":"1970","unstructured":"Geddes AM, Bridgwater FAJ, Williams DN, Oon J, Grimshaw GJ (1970) Clinical and bacteriological studies with clindamycin. Br Med J. https:\/\/doi.org\/10.1136\/bmj.2.5711.703","journal-title":"Br Med J"},{"key":"8878_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/S1081-1206(10)62718-4","author":"N Mazur","year":"1999","unstructured":"Mazur N, Greenberger PA, Regalado J (1999) Clindamycin hypersensitivity appears to be rare. Ann Allergy Asthma Immunol. https:\/\/doi.org\/10.1016\/S1081-1206(10)62718-4","journal-title":"Ann Allergy Asthma Immunol"},{"key":"8878_CR39","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-015-0826-2","author":"MN Bulloch","year":"2016","unstructured":"Bulloch MN, Baccas JT, Arnold S (2016) Clindamycin-induced hypersensitivity reaction. Infection. https:\/\/doi.org\/10.1007\/s15010-015-0826-2","journal-title":"Infection"},{"key":"8878_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2018.06.008","author":"DG Ebo","year":"2019","unstructured":"Ebo DG, Mertens C, Braes M, Mennes I, Bridts CH, Sabato V (2019) Clindamycin anaphylaxis confirmed by in vivo and in vitro testing. J Allergy Clin Immunol Pract. https:\/\/doi.org\/10.1016\/j.jaip.2018.06.008","journal-title":"J Allergy Clin Immunol Pract"},{"key":"8878_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/S1726-4901(09)70327-2","author":"C Chiou","year":"2006","unstructured":"Chiou C, Lin S, Lin S, Chang W, Chan K, Ting C (2006) Clindamycin-induced anaphylactic shock during general anesthesia. J Chin Med Assoc. https:\/\/doi.org\/10.1016\/S1726-4901(09)70327-2","journal-title":"J Chin Med Assoc"},{"key":"8878_CR42","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-4362.1998.00451.x","author":"A Mahboob","year":"1998","unstructured":"Mahboob A, Haroon TS (1998) Drugs causing fixed eruptions: a study of 450 cases. Int J Dermatol. https:\/\/doi.org\/10.1046\/j.1365-4362.1998.00451.x (PMID: 9865869)","journal-title":"Int J Dermatol"},{"key":"8878_CR43","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-1363","author":"Y Nakamura","year":"2013","unstructured":"Nakamura Y, Watamatsu K, Muto M (2013) Drug-induced hypersensitivity syndrome induced by clindamycin. Acta Derm Venereol. https:\/\/doi.org\/10.2340\/00015555-1363","journal-title":"Acta Derm Venereol"},{"key":"8878_CR44","doi-asserted-by":"publisher","DOI":"10.1002\/phar.1142","author":"A Miller Quidley","year":"2012","unstructured":"Miller Quidley A, Bookstaver BP, Gainey AB, Gainey MD (2012) Fatal clindamycin-induced drug rash with eosinophilia and systemic symptoms (DRESS) syndrome. Pharmacotherapy. https:\/\/doi.org\/10.1002\/phar.1142","journal-title":"Pharmacotherapy"},{"key":"8878_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2010.04.004","author":"D Tian","year":"2010","unstructured":"Tian D, Mohan RJ, Stallings G (2010) Drug rash with eosinophilia and systemic symptoms syndrome associated with clindamycin. Am J Med. https:\/\/doi.org\/10.1016\/j.amjmed.2010.04.004","journal-title":"Am J Med"},{"key":"8878_CR46","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2019-230077","author":"VC Hernandez","year":"2019","unstructured":"Hernandez VC, Afonso MG, Viera AC, Martin-Fernandez L (2019) Symmetrical drug-related intertriginous and flexural exanthema due to clindamycin. BMJ Case Rep. https:\/\/doi.org\/10.1136\/bcr-2019-230077","journal-title":"BMJ Case Rep"},{"key":"8878_CR47","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000020389","author":"K Aiempanakit","year":"2020","unstructured":"Aiempanakit K, Apinantriyo B (2020) Clindamycin-induced acute generalized exanthematous pustulosis: a case report. Medicine. https:\/\/doi.org\/10.1097\/MD.0000000000020389","journal-title":"Medicine"},{"key":"8878_CR48","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.12528","author":"C Croy","year":"2017","unstructured":"Croy C, Buehrle K, Szwak JA (2017) Clindamycin-associated acute generalized exanthematous pustulosis. J Clin Pharm Ther. https:\/\/doi.org\/10.1111\/jcpt.12528","journal-title":"J Clin Pharm Ther"},{"key":"8878_CR49","doi-asserted-by":"publisher","DOI":"10.1111\/ajd.12135","author":"R De Cruz","year":"2015","unstructured":"De Cruz R, Ferguson J, Wee JS, Akhras V (2015) Acute localised exanthematous pustulosis (ALEP) induced by clindamycin in pregnancy. Australas J Dermatol. https:\/\/doi.org\/10.1111\/ajd.12135","journal-title":"Australas J Dermatol"},{"key":"8878_CR50","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.142.8.1080","author":"R Kapoor","year":"2006","unstructured":"Kapoor R, Flynn C, Heald PW, Kapoor JR (2006) Acute generalized exanthematous pustulosis induced by clindamycin. Arch Dermatol. https:\/\/doi.org\/10.1001\/archderm.142.8.1080","journal-title":"Arch Dermatol"},{"key":"8878_CR51","unstructured":"Smeets TJL, Jessurun N, H\u00e4rmark L, Kardaun SH (2016) Clindamycin-induced acute generalised exanthematous pustulosis: five cases and a review of the literature. Neth J Med. PMID: 27966434"},{"key":"8878_CR52","unstructured":"Sulewski RJ, Blyumin M, Kerdel FA (2008) Acute generalized exanthematous pustulosis due to clindamycin. Dermatol Online J. PMID: 18718198"},{"key":"8878_CR53","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.13434","author":"DT Alniemi","year":"2017","unstructured":"Alniemi DT, Wetter DA, Bridges AG et al (2017) Acute generalized exanthematous pustulosis: clinical characteristics, etiologic associations, treatments, and outcomes in a series of 28 patients at Mayo Clinic, 1996\u20132013. Int J Dermatol. https:\/\/doi.org\/10.1111\/ijd.13434","journal-title":"Int J Dermatol"},{"key":"8878_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2009.03.050","author":"S Kandula","year":"2010","unstructured":"Kandula S, Burke WS, Goldfarb JN (2010) Clindamycin-induced sweet syndrome. J Am Acad Dermatol. https:\/\/doi.org\/10.1016\/j.jaad.2009.03.050","journal-title":"J Am Acad Dermatol"},{"key":"8878_CR55","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-3019","author":"K Nitta","year":"2019","unstructured":"Nitta K, Kano Y, Ushigome Y, Hayakawa J, Shiohara T (2019) Two cases of acute febrile neutrophilic dermatosis thought to be caused by topical clindamycin. Acta Derm Venereol. https:\/\/doi.org\/10.2340\/00015555-3019","journal-title":"Acta Derm Venereol"},{"key":"8878_CR56","doi-asserted-by":"publisher","DOI":"10.1592\/phco.27.9.1343","author":"BM Clark","year":"2007","unstructured":"Clark BM, Homeyer DC, Glass KR, D\u2019Avignon LC (2007) Clindamycin-induced sweet\u2019s syndrome. Pharmacotherapy. https:\/\/doi.org\/10.1592\/phco.27.9.1343","journal-title":"Pharmacotherapy"},{"key":"8878_CR57","doi-asserted-by":"publisher","DOI":"10.1159\/000199720","author":"CS Seitz","year":"2009","unstructured":"Seitz CS, Br\u00f6cker E, Trautmann A (2009) Allergy diagnostic testing in clindamycin-induced skin reactions. Int Arch Allergy Immunol. https:\/\/doi.org\/10.1159\/000199720","journal-title":"Int Arch Allergy Immunol"},{"key":"8878_CR58","doi-asserted-by":"publisher","DOI":"10.1111\/j.0105-1873.2005.00716.x","author":"MJ Notman","year":"2005","unstructured":"Notman MJ, Phillips EJ, Knowles SR, Weber EA, Shear NH (2005) Clindamycin skin testing has limited diagnostic potential. Contact Derm. https:\/\/doi.org\/10.1111\/j.0105-1873.2005.00716.x","journal-title":"Contact Derm"},{"key":"8878_CR59","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.2011.01942.x","author":"N Pereira","year":"2011","unstructured":"Pereira N, Canelas MM, Santiago F, Brites MM, Gon\u00e7alo M (2011) Value of patch tests in clindamycin-related drug eruptions. Contact Derm. https:\/\/doi.org\/10.1111\/j.1600-0536.2011.01942.x","journal-title":"Contact Derm"},{"key":"8878_CR60","doi-asserted-by":"publisher","DOI":"10.1111\/cod.13575","author":"L Gilissen","year":"2020","unstructured":"Gilissen L, Huygens S, Goossens A, Breynaert C, Schrijvers R (2020) Utility of patch testing for the diagnosis of delayed-type drug hypersensitivity reactions to clindamycin. Contact Derm. https:\/\/doi.org\/10.1111\/cod.13575","journal-title":"Contact Derm"},{"key":"8878_CR61","doi-asserted-by":"publisher","unstructured":"V\u00edlchez-S\u00e1nchez F, Dom\u00ednguez-Ortega J, Gonz\u00e1lez Mu\u00f1oz M et al (2020) Two case reports of delayed-allergic reactions to clindamycin confirmed with a positive lymphocyte transformation test. Eur Ann Allergy Clin Immunol. https:\/\/doi.org\/10.23822\/EurAnnACI.1764-1489.117.","DOI":"10.23822\/EurAnnACI.1764-1489.117"},{"key":"8878_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2018.04.004","author":"B Esty","year":"2018","unstructured":"Esty B, Minnicozzi S, Chu EC, Broyles AD, Yee CSK (2018) Successful rapid oral clindamycin desensitization in a pediatric patient. J Allergy Clin Immunol. https:\/\/doi.org\/10.1016\/j.jaip.2018.04.004","journal-title":"J Allergy Clin Immunol"},{"key":"8878_CR63","unstructured":"National Center for Biotechnology Information (2020) PubChem Compound Summary for CID 441401, Linezolid. Retrieved from https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Linezolid"},{"key":"8878_CR64","doi-asserted-by":"publisher","DOI":"10.1086\/345744","author":"MC Birmingham","year":"2003","unstructured":"Birmingham MC, Rayner CR, Meagher AK, Flavin SM, Batts DH, Schentage JJ (2003) Linezolid for the treatment of multidrug-resistant, gram-positive infections: experience from a compassionate-use program. Clin Infect Dis. https:\/\/doi.org\/10.1086\/345744","journal-title":"Clin Infect Dis"},{"key":"8878_CR65","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.50.4.1599-1602.2006","author":"E Bishop","year":"2006","unstructured":"Bishop E, Melvani S, Howden BP, Charles PGP, Grayson LM (2006) Good clinical outcomes but high rates of adverse reactions during linezolid therapy for serious infections: a proposed protocol for monitoring therapy in complex patients. Antimicrob Agents Chemother. https:\/\/doi.org\/10.1128\/AAC.50.4.1599-1602.2006","journal-title":"Antimicrob Agents Chemother"},{"key":"8878_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjid.2012.07.007","author":"M Yang","year":"2012","unstructured":"Yang M, Xu M (2012) Linezolid-induced angioedema and urticaria in a patient with renal failure. Braz J Infect Dis. https:\/\/doi.org\/10.1016\/j.bjid.2012.07.007","journal-title":"Braz J Infect Dis"},{"key":"8878_CR67","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0560.2008.01103.x","author":"FS Kim","year":"2009","unstructured":"Kim FS, Kelley W, Resh B, Goldenberg G (2009) Linezolid-induced purpuric medication reaction. J Cutan Pathol. https:\/\/doi.org\/10.1111\/j.1600-0560.2008.01103.x","journal-title":"J Cutan Pathol"},{"key":"8878_CR68","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2009.07.013","author":"S Savard","year":"2009","unstructured":"Savard S, Desmeules S, Riopel J, Agharazii M (2009) Linezolid-associated acute interstitial nephritis and drug rash with eosinophilia and systemic symptoms (DRESS) syndrome. Am J Kidney Dis. https:\/\/doi.org\/10.1053\/j.ajkd.2009.07.013","journal-title":"Am J Kidney Dis"},{"key":"8878_CR69","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1S033","author":"AD Bagwell","year":"2013","unstructured":"Bagwell AD, Stollings JL, White KD et al (2013) Linezolid desensitization for a patient with multiple medication hypersensitivity reactions. Ann Pharmacother. https:\/\/doi.org\/10.1345\/aph.1S033","journal-title":"Ann Pharmacother"},{"key":"8878_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2016.05.023","author":"H Guvenir","year":"2016","unstructured":"Guvenir H, Dibek Misirlioglu E, Toyran M, Kocabas CN (2016) Linezolid desensitization in a pediatric patient. Ann Allergy Asthma Immunol. https:\/\/doi.org\/10.1016\/j.anai.2016.05.023","journal-title":"Ann Allergy Asthma Immunol"},{"key":"8878_CR71","doi-asserted-by":"publisher","DOI":"10.1592\/phco.26.4.563","author":"MJ Cawley","year":"2006","unstructured":"Cawley MJ, Lipka O (2006) Intravenous linezolid administered orally: a novel desensitization strategy. Pharmacotherapy. https:\/\/doi.org\/10.1592\/phco.26.4.563","journal-title":"Pharmacotherapy"},{"key":"8878_CR72","unstructured":"National Center for Biotechnology Information (2020) PubChem Compound Summary for CID 4173, Metronidazole. Retrieved from https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Metronidazole"},{"key":"8878_CR73","doi-asserted-by":"publisher","DOI":"10.1097\/OLQ.0000000000000559","author":"KV Backus","year":"2017","unstructured":"Backus KV, Muzny CA, Beauchamps LS (2017) Trichomonas vaginalis treated with boric acid in a metronidazole allergic female. Sex Transm Dis. https:\/\/doi.org\/10.1097\/OLQ.0000000000000559","journal-title":"Sex Transm Dis"},{"key":"8878_CR74","unstructured":"Asensio S\u00e1nchez T, D\u00e1vila I, Moreno E et al (2008) Anaphylaxis due to metronidazole with positive skin prick test. J Investig Allergol Clin Immunol. PMID: 18447147"},{"key":"8878_CR75","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.2006.01064.x","author":"JT Madsen","year":"2007","unstructured":"Madsen JT, Thormann J, Kerre S, Andersen KE, Goossens A (2007) Allergic contact dermatitis to topical metronidazole - 3 cases. Contact Derm. https:\/\/doi.org\/10.1111\/j.1600-0536.2006.01064.x","journal-title":"Contact Derm"},{"key":"8878_CR76","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2013-200470","author":"N Kumar","year":"2013","unstructured":"Kumar N, Sundriyal D, Walia M, Trisal D (2013) Metronidazole-induced fixed drug eruption. BMJ Case Rep. https:\/\/doi.org\/10.1136\/bcr-2013-200470","journal-title":"BMJ Case Rep"},{"key":"8878_CR77","doi-asserted-by":"publisher","DOI":"10.1111\/j.0105-1873.2005.0407a.x","author":"A Prieto","year":"2005","unstructured":"Prieto A, De Barrio M, Infante S, Torres A, Rubio M, Olalde S (2005) Recurrent fixed drug eruption due to metronidazole elicited by patch test with tinidazole. Contact Derm. https:\/\/doi.org\/10.1111\/j.0105-1873.2005.0407a.x","journal-title":"Contact Derm"},{"key":"8878_CR78","doi-asserted-by":"publisher","DOI":"10.1001\/archdermatol.2010.419","author":"MD Hermida","year":"2011","unstructured":"Hermida MD, Consalvo L, Lapadula MM, Giovanna PD, Cabrera HN (2011) Bullous fixed drug eruption induced by intravaginal metronidazole ovules, with positive topical provocation test findings. Arch Dermatol. https:\/\/doi.org\/10.1001\/archdermatol.2010.419","journal-title":"Arch Dermatol"},{"key":"8878_CR79","doi-asserted-by":"publisher","DOI":"10.1157\/13086750","author":"I Garc\u00eda-Rubio","year":"2006","unstructured":"Garc\u00eda-Rubio I, Mart\u00ednez-C\u00f3cera C, Santos Magad\u00e1n S, Rodr\u00edguez-Jim\u00e9nez B, V\u00e1zquez-Cort\u00e9s S (2006) Hypersensitivity reactions to metronidazole. Allergol Immunopathol. https:\/\/doi.org\/10.1157\/13086750","journal-title":"Allergol Immunopathol"},{"key":"8878_CR80","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.12448","author":"HZ VanCleave","year":"2016","unstructured":"VanCleave HZ, Sanchez AC, Lieberman JA, Ellenburg JT, Mabry WQ (2016) Probable metronidazole induced serum sickness-like reaction in a paediatric patient. J Clin Pharm Ther. https:\/\/doi.org\/10.1111\/jcpt.12448","journal-title":"J Clin Pharm Ther"},{"key":"8878_CR81","doi-asserted-by":"publisher","DOI":"10.4103\/0253-7613.125193","author":"G Mazumdar","year":"2014","unstructured":"Mazumdar G, Shome K (2014) Stevens-Johnson Syndrome following use of metronidazole in a dental patient. Indian J Pharmacol. https:\/\/doi.org\/10.4103\/0253-7613.125193","journal-title":"Indian J Pharmacol"},{"key":"8878_CR82","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.2006.00904.x","author":"G Piskin","year":"2006","unstructured":"Piskin G, Mekkes JR (2006) Stevens-Johnson Syndrome from metronidazole. Contact Derm. https:\/\/doi.org\/10.1111\/j.1600-0536.2006.00904.x","journal-title":"Contact Derm"},{"key":"8878_CR83","doi-asserted-by":"publisher","unstructured":"Watsky KL (1999) Acute generalized exanthematous pustulosis induced by metronidazole: the role of patch testing. Archi Dermatol.\u00a0https:\/\/doi.org\/10.1001\/archderm.135.1.93.\u00a0Available on PubMed at: https:\/\/pubmed.ncbi.nlm.nih.gov\/9923793\/","DOI":"10.1001\/archderm.135.1.93"},{"key":"8878_CR84","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.15274","author":"M Kostaki","year":"2019","unstructured":"Kostaki M, Polydorou D, Adamou E, Chasapi V, Antoniou C, Stratigos A (2019) Acute localized exanthematous pustulosis due to metronidazole. J Eur Acad Dermatol Venereol. https:\/\/doi.org\/10.1111\/jdv.15274","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"8878_CR85","doi-asserted-by":"publisher","DOI":"10.3109\/15569527.2013.823981","author":"A Sikar Akt\u00fcrk","year":"2014","unstructured":"Sikar Akt\u00fcrk A, Bayramg\u00fcrler D, Salman S, Y\u0131ld\u0131z DK, Demirsoy EO (2014) Symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) induced by oral metronidazole. Cutan Ocul Toxicol. https:\/\/doi.org\/10.3109\/15569527.2013.823981","journal-title":"Cutan Ocul Toxicol"},{"key":"8878_CR86","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1Q478","author":"K Seto","year":"2012","unstructured":"Seto K, Knowles SR, Weber EA (2012) Immediate hypersensitivity reaction induced by metronidazole. Ann Pharmacother. https:\/\/doi.org\/10.1345\/aph.1Q478","journal-title":"Ann Pharmacother"},{"key":"8878_CR87","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4362.1990.tb03788.x","author":"D Mishra","year":"1990","unstructured":"Mishra D, Mobashir M, Zaheer SM (1990) Fixed drug eruption and cross-reactivity between tinidazole and metronidazole. Int J Dermatol. https:\/\/doi.org\/10.1111\/j.1365-4362.1990.tb03788.x","journal-title":"Int J Dermatol"},{"key":"8878_CR88","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2007.10.795","author":"DJ Helms","year":"2008","unstructured":"Helms DJ, Mosure DJ, Secor EW, Workowski KA (2008) Management of trichomonas vaginalis in women with suspected metronidazole hypersensitivity. Am J Obstet Gynecol. https:\/\/doi.org\/10.1016\/j.ajog.2007.10.795","journal-title":"Am J Obstet Gynecol"},{"key":"8878_CR89","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(91)90341-k","author":"ML Kurohara","year":"1991","unstructured":"Kurohara ML, Kwong FK, Lebherz TB, Klaustermeyer WB (1991) Metronidazole hypersensitivity and oral desensitization. J Allergy Clin Immunol. https:\/\/doi.org\/10.1016\/0091-6749(91)90341-k","journal-title":"J Allergy Clin Immunol"},{"key":"8878_CR90","doi-asserted-by":"publisher","DOI":"10.2500\/ar.2014.5.0080","author":"SR Gendelman","year":"2014","unstructured":"Gendelman SR, Pien LC, Gutta RC, Abouhassan SR (2014) Modified oral metronidazole desensitization protocol. Allergy Rhinol. https:\/\/doi.org\/10.2500\/ar.2014.5.0080","journal-title":"Allergy Rhinol"},{"key":"8878_CR91","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(96)70329-0","author":"MD Pearlman","year":"1996","unstructured":"Pearlman MD, Yashar C, Ernst S, Solomon W (1996) An incremental dosing protocol for women with severe vaginal trichomoniasis and adverse reactions to metronidazole. Am J Obstet Gynecol. https:\/\/doi.org\/10.1016\/S0002-9378(96)70329-0","journal-title":"Am J Obstet Gynecol"},{"key":"8878_CR92","doi-asserted-by":"crossref","unstructured":"Bradley JS, Barnett ED, Cantey JB et al (2018) Preferred therapy for specific bacterial and mycobacterial pathogens. Nelson\u2019s Pediatric Antimicrobial Therapy. Am Acad Pediatr 119\u2013142","DOI":"10.1542\/9781610021104-ch07"}],"container-title":["Clinical Reviews in Allergy &amp; Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-021-08878-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12016-021-08878-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-021-08878-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T02:30:18Z","timestamp":1653964218000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12016-021-08878-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,15]]},"references-count":92,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["8878"],"URL":"https:\/\/doi.org\/10.1007\/s12016-021-08878-x","relation":{},"ISSN":["1559-0267"],"issn-type":[{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,15]]},"assertion":[{"value":"13 July 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}